CD44 and hepatocellular carcinoma: Liposomal NP (LNP) incorporated paclitaxel or coated anti-CD44 antibody loaded with a suicide gene or doxorubicin induced therapeutic effects in CD44-positive metastatic ovarian cancer cells or hepatocellular carcinoma cells [96,97].